跳至主要内容

MedPath Trial Home

机构资讯 AI 研究

数据来源：ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

搜索试验。追踪管线。洞察审批。由 AI 驱动的临床研究情报平台。

产品

临床试验
药物情报
全球审批
深度研究
价格方案

资源

常见问题
搜索

公司

资讯
关于我们
联系我们

法律

隐私政策
服务条款

免责声明： 本网站提供信息检索和数据分析服务。内容不构成医疗建议。适应性评估仅供参考，不能替代合格医疗专业人员的咨询。数据来源于公共注册库和监管机构；MedPath 不保证数据的完整性或准确性。请以原始资料为准。

© 2026 MedPath Trial 版权所有

服务条款隐私政策

我们重视您的隐私

我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。

Ferring Pharmaceuticals A/S

首页临床试验发起方与机构Ferring Pharmaceuticals A/S

Ferring Pharmaceuticals A/S

ACTIVE

丹麦www.ferring.comSubsidiary

隶属于 Ferring Holding SA

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

相关临床试验

185

169 进行中

药物批准

20

批准总数

监管机构

3

监管机构数

成立时间

N/A

概览

试验阶段分布

阶段

试验数

占比

1 期

94

50.8%

3 期

3

1.6%

2 期

2

1.1%

4 期

1

0.5%

试验状态分布

进行中（未招募）

169

91.3%

已完成

3

1.6%

招募中

12

6.5%

撤回

1

0.5%

相关临床试验

该机构主办的试验（185）

An exploratory study to investigate the effect of FE 999302 when given during different time periods to women undergoing controlled ovarian stimulation with follitropin delta

Feb 2024200 名受试者

An exploratory study to investigate the effect of FE 999302 when given together with follitropin delta during controlled ovarian stimulatio

Feb 2024600 名受试者

A study in healthy subjects investigating the safety, tolerability and concentrations of FE 999301 after single and multiple doses

Nov 202348 名受试者

A trial to compare efficacy and safety of follitropin delta versus placebo (inactive treatment) in the treatment of men with idiopathic infertility (unexplained reduction of semen quality).

Oct 2023400 名受试者

A trial to compare the ovarian response of REKOVELLE and GONAL-F in conventional dosing in women undergoing controlled ovarian stimulatio

Jun 2023300 名受试者

Clinical research study to learn about the effect and safety of different doses of FE 999302 when given as a single dose for final development of the eggs after ovarian stimulatio

进行中（未招募）

Aug 2022500 名受试者

MENOPUR and REKOVELLE in Women UnderGoing an assisted reproductive technology cycle

进行中（未招募）

Jul 2022151 名受试者

A trial to compare efficacy and safety of follitropin delta versus placebo (inactive treatment) in the treatment of men with idiopathic infertility (unexplained reduction of semen quality).

进行中（未招募）

Apr 2022400 名受试者

第 1 页，共 24 页

药物批准

按机构分类的批准

NMPA

National Medical Products Administration

7

药物批准

EMA

European Medicines Agency

3

药物批准

CIMA_AEMPS

Spanish Agency for Medicines and Medical Devices

10

药物批准

近期批准

Human Follitropin Delta Injection

Human Follitropin delta Injection

Human Follitropin delta Injection

Degarelix Acetate for Injection

Degarelix Acetate for Injection

Degarelix Acetate for Injection

Degarelix Acetate for Injection

REKOVELLE 12 MICROGRAMOS/0,36 ML SOLUCION INYECTABLE EN PLUMA PRECARGADA

REKOVELLE 36 MICROGRAMOS/1,08 ML SOLUCION INYECTABLE EN PLUMA PRECARGADA

REKOVELLE 72 MICROGRAMOS/2,16 ML SOLUCION INYECTABLE EN PLUMA PRECARGADA

资讯

暂无资讯文章

本页目录

概览
相关临床试验185
药物批准20
资讯

返回机构列表